Your strategic partner in advancing patient health

TMC is a global pharma services company partnering with small to mid-sized biotech and pharma companies to accelerate drug development timelines and maximise value across the full product lifecycle. 

We provide end-to-end support — from early-stage clinical development to clinical execution, market access and drug commercialisation. Our integrated pharma services are delivered by cross-functional experts with extensive knowledge across regulatory, clinical development, medical services, pharmacovigilance and quality specialities. 

Whether you're advancing a rare disease treatment, pioneering an advanced therapeutic modality or preparing for market entry in the EU and UK, TMC is the pharma services company with the agility, insight and infrastructure to make it happen. 

Be part of our

RARE CONVERSATIONS

Will we ever have fully decentralised clinical trials in rare diseases?  

Which drug development solution do you need? 

Access cross-functional expertise to accelerate your drug development timeline  

TMC Consulting provides expert-led strategic and operational pharma consultancy services — spanning drug regulatory affairs, clinical development, pharmacovigilance, medical services and quality management.   

Our experienced specialists partner flexibly with you, integrating key roles and pharma services into your team to help you reach critical drug development milestones compliantly, quickly and cost-effectively. 

Conduct seamless early-phase clinical trials for advanced therapeutics 

TMC Clinical specialises in early-phase clinical development solutions for rare disease, complex oncology and advanced therapeutic modalities.  

We combine the responsiveness of a specialist pharma services company with the expertise of a clinical research organisation, enabling you to accelerate your drug development timelines, reduce risk and move confidently towards global new drug approvals. 

Gain EU and UK market access quickly and confidently 

TMC Commercial provides flexible, full-service drug commercialisation services in the EU and UK — from preparing for submission to post-authorisation — giving you the confidence and opportunity to build your own commercial presence without needing to out-license to a partner.  

We also have the specialist expertise to act as your Marketing Authorisation Holder (MAH), either as a temporary bridge or long-term solution.  

What our clients say…   

‘Thank you… and I must take a moment and specifically let you know how well-regarded you are here and how grateful we are to be working with you.’
Chief Operating Officer, global biotech client
‘I cannot even begin to thank you for all your hard work over the last few weeks driving toward database lock. Every time there seemed to be a light at the end of the tunnel, we added another hurdle! You handled absolutely everything we threw at you brilliantly!’
Head Clinical Project Manager, biotech client
‘Very happy to have you and the TMC team on our side as our partner! This is a really important project for us, and I can’t think of anyone else I would want in my corner — thank you!’
Chief Scientific Officer, global biopharma client
‘I would like to thank you and all the TMC team for a very successful collaboration. The quality of service received contributed to the project outcomes, with every step of the process delivered seamlessly and professionally.’
Research Project Manager, global pharmaceutical client
‘Your support and partnership are greatly appreciated and have been instrumental in delivering this milestone.’
CMO, global biotech client

Want to navigate complexity and accelerate your drug development timeline while retaining control and maximising value? TMC is the pharma services company for you.  

Contact our team today to find out more about our drug development solutions and see how TMC, as your strategic partner, can help you bring transformative therapies to patients faster.